Cervical cancer [DS:H00030] Vulvar cancer [DS:H00029] Oropharyngeal cancer [DS:H01559] Anal cancer [DS:H00044] Head and neck cancer [DS:H02420] Genital warts [DS:H01418]
Comment
Prevention of diseases caused by human papillomavirus (HPV) types 16, 18, 31, 33, 45, 52, and 58
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J07 VACCINES
J07B VIRAL VACCINES
J07BM Papillomavirus vaccines
J07BM03 Papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58)
D11863 Human papillomavirus 9-valent vaccine, recombinant <JP/US>
USP drug classification [BR:br08302]
Immunological Agents
Vaccines
Human Papillomavirus (HPV)
Human Papillomavirus 9-valent Vaccine
D11863 Human papillomavirus 9-valent vaccine, recombinant
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
63 Biological preparations
631 Vaccines
6313 Viral vaccines
D11863 Human papillomavirus 9-valent vaccine, recombinant
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D11863
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D11863